as on September 18, 2025 at 1:29 am IST
Day's Low
Day's High
5.08%
Downside
1.69%
Upside
52 Week's Low
52 Week's High
32.20%
Downside
120.34%
Upside
Check Neurosense Therapeutics Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$29.6M
EPS (TTM)
-0.4
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-8.6M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
357700.00%
Compare market cap, revenue, PE, and other key metrics of Neurosense Therapeutics Ltd with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $29.6M | NA | NA | 0.00% | |
BUY | $60.5B | 248.74% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $99.3B | 45.88% | 27.56 | 31.86% | |
BUY | $60.9B | 5.45% | 14.49 | 31.37% |
The Neurosense Therapeutics Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Neurosense Therapeutics Ltd investment value today
Current value as on today
₹92,006
Returns
Returns from Neurosense Therapeutics Ltd Stock
Dollar Returns*
₹4,598 (+4.6%)
Based on 8 analysts
87.50%
Buy
12.50%
Hold
0.00%
Sell
Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Neurosense Therapeutics Ltd. Average target price of $14
Get share price movements and forecasts by analysts on Neurosense Therapeutics Ltd.
What analysts predicted
91.57%UPSIDE
Target Price
$14
Current Price
$1.18
Analyzed by
8 Analysts
Target
$14.00
Neurosense Therapeutics Ltd target price $14, a slight upside of 91.57% compared to current price of $1.18. According to 8 analysts rating.
Search interest for Neurosense Therapeutics Ltd Stock has increased by 311% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:311% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 151.6%
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 81.0%
Price Dip
In the last 3 months, NRSN stock has moved down by -51.8%
Organisation | Neurosense Therapeutics Ltd |
Headquarters | Building B, Herzliya, Israel, 4672562 |
CEO | Mr. Alon Ben-Noon |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Eidan Loushi | Lead C.R.A. |
Mr. Alon Ben-Noon | Co-Founder, CEO & Director |
Mr. Or Eisenberg | Chief Financial Officer |
Dr. Niva Russek-Blum Ph.D. | Chief Technology Officer |
Dr. Ferenc Tracik M.D. | Chief Medical Officer |
Ms. Yael Barak | VP of Quality & Compliance |
Ms. Keren Pushett | Head of HR |
Neurosense Therapeutics Ltd share price today is $1.18 as on at the close of the market. Neurosense Therapeutics Ltd share today touched a day high of $1.2 and a low of $1.12.
Neurosense Therapeutics Ltd share touched a 52 week high of $2.6 on and a 52 week low of $0.8 on . Neurosense Therapeutics Ltd stock price today i.e. is closed at $1.18,which is 54.62% down from its 52 week high and 47.50% up from its 52 week low.
Neurosense Therapeutics Ltd market capitalisation is $0.00T as on .
Indian investors can start investing in Neurosense Therapeutics Ltd (NRSN) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Neurosense Therapeutics Ltd stock (as per the Rupee-Dollar exchange rate as on ).
Based on Neurosense Therapeutics Ltd share’s latest price of $1.18 as on September 18, 2025 at 1:29 am IST, you will get 8.4746 shares of Neurosense Therapeutics Ltd. Learn more about
fractional shares .